{"database": "lobbying", "table": "lobbying_activities", "rows": [[838737, "f798747a-832d-48a7-8496-f73df534d49d", "Q3", "THE OB-C GROUP, LLC", 29802, "ELI LILLY", 2009, "third_quarter", "PHA", "HR 1548, Pathway for Biosimilars Act: entire bill.\nNo specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2009-10-19T14:59:33-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["838737"], "units": {}, "query_ms": 18.727257032878697, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}